Greener Generic Drug Manufacturing – Biotransformation for a Sustainable Supply Chain
Information
As pharmaceutical companies push toward bold sustainability goals, transforming manufacturing processes for generic drugs is becoming a vital focus. While advancements in energy efficiency, packaging reduction, and logistics play a role, the most meaningful environmental impact may be found further upstream in cleaner, more sustainable approaches to material sourcing and production.
Emerging technologies like biocatalysis, synthetic biology, and fermentation-based methods present compelling alternatives to conventional chemical synthesis. These biotransformation techniques can significantly lower environmental footprints, improve process efficiency, and enhance scalability. However, broader adoption faces hurdles including technical barriers, cost implications, and regulatory complexity.
